Eosinophilic Esophagitis (EoE)

The AJMC® Eosinophilic Esophagitis (EoE) compendium is a comprehensive resource for clinical news and expert insights for the chronic immune system disease. EoE is an allergic condition in which the esophagus becomes inflamed and cannot contract properly

Linked Color Imaging May Improve Diagnostic Accuracy for Eosinophilic Esophagitis

July 28th 2022, 5:55pm


Diagnostic accuracy for eosinophilic esophagitis (EoE) was higher when white light images were used with linked color imaging rather than alone, suggesting that linked color imaging may be used to reduce diagnostic disparities among endoscopists.

Case Study Details Challenges in Eosinophilic Gastritis Management

July 21st 2022, 12:10pm


Nonspecific clinical symptoms can make identifying eosinophilic gastritis difficult, but detailed examination, biopsy, and testing can rule out other possible causes of eosinophilic infiltration of the gastric mucosa.

Dupilumab Shows Positive Results in Children With EoE as Young as Age 1

July 14th 2022, 7:10pm


A late-stage trial of dupilumab in young children showed the biologic induced remission in eosinophilic esophagitis (EoE).

Delayed Gastric Emptying May Affect a Subset of Patients With Eosinophilic Esophagitis

July 8th 2022, 3:55pm


A small study of children with eosinophilic esophagitis found that certain patients might benefit from gastric emptying nuclear medicine studies.

Dupilumab Demonstrates Safety, Efficacy Across Several Type 2 Inflammatory Diseases

July 2nd 2022, 10:01pm


Research presented at the European Academy of Allergy and Clinical Immunology Annual Congress show the safety and efficacy of dupilumab across several progressive diseases with underlying type 2 inflammation, including eosinophilic esophagitis (EoE), severe asthma, and severe chronic rhinosinusitis with nasal polyps.

Sponge Cytology “Moderately Successful” at Guiding Food Reintroduction in EoE

June 23rd 2022, 12:33pm


The data suggest the noninvasive procedure was successful in guiding food reintroduction, but missed some food triggers in certain patients.

Dupilumab Efficacy in Asthma, AD, EoE, and CRSwNP Not Affected By Eosinophil Count

June 8th 2022, 5:20pm


Dupilumab-induced increases in mean eosinophil counts were shown to wane over time in patients with asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and atopic dermatitis (AD), with incidence of eosinophilia not shown to reduce efficacy of the biologic.

Review of Current EoE Treatment Landscape Highlights Several Promising Agents

May 31st 2022, 7:12pm


A recent review points to a host of potentially disease-modifying agents currently in clinical trials.

Assessing Comorbidities in Eosinophilic Esophagitis

May 27th 2022, 4:39pm


Investigators in Spain evaluated symptoms and comorbidities associated with eosinophilic esophagitis.

FDA Approves Dupilumab as First Therapy for Eosinophilic Esophagitis

May 20th 2022, 7:56pm


Eosinophilic esophagitis is a chronic inflammatory disorder in which eosinophils, a type of white blood cell, proliferate in the esophagus, causing difficulties with eating and swallowing.